$29.15 -0.42 (%) Pfizer Inc - NYSE

Oct. 1, 2014 | 04:00 PM

Partner Headlines

  1. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  2. Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down?

    Benzinga | Sep. 29, 2014 | 12:55PM EST
  3. Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26

    Benzinga | Sep. 27, 2014 | 10:33AM EST
  4. Focusing Solely On Animal Health Sets Zoetis Apart

    IBD | Sep. 26, 2014 | 14:37PM EST
  5. GlycoMimetics Reports Delay in Initiation of Phase 3 Trial with Rivipansel

    Benzinga | Sep. 26, 2014 | 09:03AM EST
  6. Fast Money Picks For September 26 - Pfizer Inc., The Dow Chemical Company And More

    Benzinga | Sep. 25, 2014 | 20:26PM EST
  7. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  8. Pfizer

    IBD | Sep. 23, 2014 | 18:45PM EST
  9. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  10. Inversions Thwarted, But Real Tax Fix Needs Congress

    IBD | Sep. 23, 2014 | 18:28PM EST
  11. Stocks Finish Lower Among Takeover Rumors

    IBD | Sep. 23, 2014 | 18:06PM EST
  12. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  13. Pfizer Inc. Is Kicking The Tires At Actavis PLC

    Benzinga | Sep. 23, 2014 | 14:45PM EST
  14. The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

    GuruFocus | Sep. 16, 2014 | 16:58PM EST
  15. The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

    GuruFocus | Sep. 16, 2014 | 15:16PM EST
  16. MedGenesis Announces Deal with Pfizer Related to Possible Treatments for Parkinson's

    Benzinga | Sep. 16, 2014 | 09:10AM EST
  17. Nasdaq Underperforms As Leading Growth Stocks Take Heat

    IBD | Sep. 15, 2014 | 11:49AM EST
  18. Benzinga's Weekend M&A Chatter

    Benzinga | Sep. 14, 2014 | 18:15PM EST
  19. Why Nine of Fifteen Oil Majors Are Undervalued

    YCharts | Sep. 12, 2014 | 18:34PM EST
  20. Pfizer Inc. Trying To Claw Its Way Back Up After Pullback

    Benzinga | Sep. 10, 2014 | 10:33AM EST
  21. Martoma Hit with Nine-Year Prison Sentence

    FoxBusiness | Sep. 8, 2014 | 16:44PM EST
  22. What Is A High Risk Market?

    Benzinga | Sep. 8, 2014 | 09:39AM EST
  23. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  24. SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely'

    Benzinga | Sep. 2, 2014 | 15:35PM EST
  25. Partnering With Big Pharma, Parexel Hits Its Stride

    IBD | Aug. 29, 2014 | 16:14PM EST
  26. Amgen edges up on trial results

    IBD | Aug. 28, 2014 | 18:42PM EST
  27. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus | Aug. 28, 2014 | 13:52PM EST
  28. UPDATE: Protalix Shares Spike Higher on FDA Approval of Pediatric Indication for ELELYSO(TM) for Injection, for IV Use for Treatment of Type 1 Gaucher Disease

    Benzinga | Aug. 28, 2014 | 13:18PM EST
  29. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus | Aug. 28, 2014 | 12:21PM EST
  30. Fast Money Picks For August 28

    Benzinga | Aug. 27, 2014 | 20:35PM EST
  31. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  32. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  33. Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive Pipeline

    Benzinga | Aug. 27, 2014 | 11:25AM EST
  34. Benzinga's Top Initiations

    Benzinga | Aug. 27, 2014 | 09:26AM EST
  35. Deutsche Bank Initiates Pfizer With Buy

    Benzinga | Aug. 27, 2014 | 07:06AM EST
  36. Merck, Pfizer combining drugs

    IBD | Aug. 26, 2014 | 18:45PM EST
  37. HCP Boosts Of 29 Years Of Dividend Increases

    IBD | Aug. 26, 2014 | 17:27PM EST
  38. Economic Data Fuel Another All-Time High For S&P 500

    IBD | Aug. 26, 2014 | 15:36PM EST
  39. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  40. Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer Combo Regimen

    Benzinga | Aug. 26, 2014 | 08:01AM EST
  41. Late-Cycle Nirvana: Moaty Dividends on the Cheap

    YCharts | Aug. 25, 2014 | 23:48PM EST
  42. 3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology

    Benzinga | Aug. 24, 2014 | 20:08PM EST
  43. Nasdaq Leads Mixed Session; Actavis Extends Gains

    IBD | Aug. 22, 2014 | 13:27PM EST
  44. Contract Researcher Parexel Sees Growth In Biotech

    IBD | Aug. 21, 2014 | 15:00PM EST
  45. Illumina Forms Partnerships With Big Pharma Firms

    IBD | Aug. 21, 2014 | 12:03PM EST
  46. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga | Aug. 21, 2014 | 11:39AM EST
  47. Treasury Develolping Options to Curb Inversions

    FoxBusiness | Aug. 18, 2014 | 13:34PM EST
  48. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus | Aug. 18, 2014 | 11:54AM EST
  49. Pfizer Announces Submission of Palbociclib New Drug Application To The FDA

    Benzinga | Aug. 18, 2014 | 08:01AM EST
  50. Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine

    Benzinga | Aug. 14, 2014 | 17:01PM EST
Trading Center